SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-041796
Filing Date
2024-04-04
Accepted
2024-04-04 16:05:15
Documents
2
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1583
2 EX-24 aura-ex24.htm EX-24 12408
  Complete submission text file 0000950170-24-041796.txt   15374
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
Kilroy Conor (Reporting) CIK: 0001808510 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40971 | Film No.: 24823142